ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,485Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 16

$660K Total Retail Price of All Prescriptions

Rank: 2 out of 16

341 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 341 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

24% of this provider’s 341 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,714 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 438 238 1 3
HYDROCODONE-ACETAMINOPHEN 421 265 S3 2 4
AMLODIPINE BESYLATE 415 324 3 5
OMEPRAZOLE 414 251 4 1
CARVEDILOL 348 270 5 22
SIMVASTATIN 298 249 6 2
ATORVASTATIN CALCIUM 296 190 7 12
METFORMIN HCL 212 108 8 7
FUROSEMIDE 212 173 8 8
LOSARTAN POTASSIUM 203 169 10 10
NEXIUM 203 128 10 17
WARFARIN SODIUM 176 148 12 16
GABAPENTIN 166 76 13 13
AMLODIPINE BESYLATE-BENAZEPRIL 146 88 14 56
OXYCODONE HCL 138 57 S2 15 51
HYDROCHLOROTHIAZIDE 135 105 16 11
ATENOLOL 134 103 17 25
LEVOTHYROXINE SODIUM 116 55 18 6
TRAMADOL HCL 115 63 19 24
ZOLPIDEM TARTRATE 107 39 20 15
METOPROLOL TARTRATE 100 71 21 14
PRAVASTATIN SODIUM 94 53 22 9
SPIRIVA 90 56 23 53
METOPROLOL SUCCINATE 88 63 24 19
CELEBREX 88 64 24 73
LOVASTATIN 81 55 26 61
SERTRALINE HCL 79 39 27 32
CRESTOR 74 38 28 27
POTASSIUM CHLORIDE 69 58 29 18
NOVOLOG FLEXPEN 68 40 30 98
CYCLOBENZAPRINE HCL 67 24 R 31 57
BENICAR 66 33 32 100
DONEPEZIL HCL 66 66 32 42
ADVAIR DISKUS 64 48 34 49
LIPITOR 61 49 35 107
MORPHINE SULFATE ER 61 13 S2 35 107
DOXAZOSIN MESYLATE 59 24 37 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 32 37 21
DIOVAN HCT 58 56 39 72
LOSARTAN-HYDROCHLOROTHIAZIDE 58 39 39 43
TEKTURNA 58 51 39 111
METFORMIN HCL ER 56 52 42 115
HYDRALAZINE HCL 56 50 42 79
EXFORGE 55 44 44 118
DIOVAN 54 42 45 50
OXYCODONE-ACETAMINOPHEN 53 19 S2 46 59
DILTIAZEM HCL 52 31 47 130
CLONIDINE HCL 51 23 48 84
ISOSORBIDE MONONITRATE ER 50 42 49 39
FENTANYL 50 32 S2 49 55
NIFEDIPINE ER 50 26 49 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.